Examkin

Question

Difficulty: MediumHematology and Oncology

A 38-year-old woman presents to the emergency department with a 3-day history of spontaneous mucosal bleeding, easy bruising, and extreme fatigue. Laboratory studies reveal a leukocyte count of 45,000/mm³, hemoglobin of 7.9 g/dL, and platelet count of 18,000/mm³. Coagulation panel shows a prolonged prothrombin time, prolonged activated partial thromboplastin time, elevated D-dimer, and profoundly decreased fibrinogen levels. Acute promyelocytic leukemia (APL) is highly suspected based on the presentation of pancytopenia with disseminated intravascular coagulation (DIC).

Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the management of this patient.

  1. 1Evaluate the peripheral blood smear for atypical promyelocytes and Auer rods
  2. 2Administer all-trans retinoic acid (ATRA) empirically
  3. 3Perform a bone marrow aspiration and biopsy for cytogenetic and molecular testing
  4. 4Initiate definitive induction chemotherapy tailored to molecular results

Answer

The correct sequence is to first evaluate the peripheral blood smear, immediately administer empirical all-trans retinoic acid (ATRA), followed by bone marrow evaluation for genetic testing, and finally tailor definitive induction chemotherapy once molecular results are confirmed.
The correct sequence for managing suspected acute promyelocytic leukemia (APL) prioritizes the immediate mitigation of its most fatal complication: disseminated intravascular coagulation (DIC). Upon clinical and laboratory suspicion, a peripheral smear provides rapid, non-invasive support by demonstrating atypical promyelocytes. Crucially, all-trans retinoic acid (ATRA) must be administered immediately upon this suspicion to promote cellular differentiation and halt the coagulopathy. An invasive bone marrow biopsy is performed only after ATRA is initiated. Finally, definitive induction chemotherapy is tailored once molecular confirmation is finalized.

Step-by-Step Solution

1
Evaluate the peripheral blood smear.
Rapid visual identification of atypical promyelocytes with multiple Auer rods.
Provides immediate, non-invasive support for the diagnosis of APL in a patient with suspected DIC.
2
Administer all-trans retinoic acid (ATRA).
Leukemic cells begin to differentiate into mature granulocytes.
ATRA reverses the coagulopathy of APL and must be given emergently on clinical suspicion alone to prevent fatal hemorrhage.
3
Perform a bone marrow aspiration and biopsy.
Tissue is obtained for cytogenetics and FISH for the PML-RARA fusion gene.
Required for the definitive diagnosis of APL, but should only be performed after ATRA is started to avoid delaying life-saving therapy.
4
Initiate definitive induction chemotherapy.
Targeted agents (like arsenic trioxide) are added to the regimen.
Long-term consolidation and definitive induction are tailored once the molecular diagnosis and risk stratification are finalized.

Key Concept

Algorithmic management of suspected Acute Promyelocytic Leukemia (APL)
Rate this question

Topics

Hematology and Oncology

More questions from this topic